Return On Assets of GT Biopharma, Inc. from 31 Mar 2012 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
GT Biopharma, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2012 to 31 Dec 2024.
  • GT Biopharma, Inc. Return On Assets for the quarter ending 31 Dec 2024 was -175%, a 293% decline year-over-year.
  • GT Biopharma, Inc. annual Return On Assets for 2024 was -175%, a 293% decline from 2023.
  • GT Biopharma, Inc. annual Return On Assets for 2023 was -44%, a 53% increase from 2022.
  • GT Biopharma, Inc. annual Return On Assets for 2022 was -93%.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

GT Biopharma, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2024 -175% -130% -293% 01 Oct 2024 31 Dec 2024
Q3 2024 -123% -66% -115% 01 Jul 2024 30 Sep 2024
Q2 2024 -92% -15% -19% 01 Apr 2024 30 Jun 2024
Q1 2024 -66% +10% +13% 01 Jan 2024 31 Mar 2024
Q4 2023 -44% +49% +53% 01 Oct 2023 31 Dec 2023
Q3 2023 -57% +70% +55% 01 Jul 2023 30 Sep 2023
Q2 2023 -77% 01 Apr 2023 30 Jun 2023
Q1 2023 -76% 01 Jan 2023 31 Mar 2023
Q4 2022 -93% 01 Oct 2022 31 Dec 2022
Q3 2022 -127% 01 Jul 2022 30 Sep 2022
Q4 2020 -1426% -1130% -381% 01 Oct 2020 31 Dec 2020
Q3 2020 -3516% -3301% -1537% 01 Jul 2020 30 Sep 2020
Q2 2020 -9030% -8071% -842% 01 Apr 2020 30 Jun 2020
Q1 2020 -533% -228% -75% 01 Jan 2020 31 Mar 2020
Q4 2019 -297% -113% -61% 01 Oct 2019 31 Dec 2019
Q3 2019 -215% -83% -63% 01 Jul 2019 30 Sep 2019
Q2 2019 -959% -898% -1474% 01 Apr 2019 30 Jun 2019
Q1 2019 -305% -227% -293% 01 Jan 2019 31 Mar 2019
Q4 2018 -184% -71% -63% 01 Oct 2018 31 Dec 2018
Q3 2018 -132% +88% +40% 01 Jul 2018 30 Sep 2018
Q2 2018 -61% +11965% +99% 01 Apr 2018 30 Jun 2018
Q1 2018 -78% +5005% +98% 01 Jan 2018 31 Mar 2018
Q4 2017 -113% -6803% -102% 01 Oct 2017 31 Dec 2017
Q3 2017 -220% +8600% +98% 01 Jul 2017 30 Sep 2017
Q2 2017 -12026% -2800% -30% 01 Apr 2017 30 Jun 2017
Q1 2017 -5082% -25287% -125% 01 Jan 2017 31 Mar 2017
Q4 2016 6690% +11862% 01 Oct 2016 31 Dec 2016
Q3 2016 -8820% -6577% -293% 01 Jul 2016 30 Sep 2016
Q2 2016 -9226% -7132% -341% 01 Apr 2016 30 Jun 2016
Q1 2016 20204% +25880% 01 Jan 2016 31 Mar 2016
Q4 2015 -5171% +188% +3.5% 01 Oct 2015 31 Dec 2015
Q3 2015 -2243% -194% -9.5% 01 Jul 2015 30 Sep 2015
Q2 2015 -2093% -684% -48% 01 Apr 2015 30 Jun 2015
Q1 2015 -5676% -4526% -393% 01 Jan 2015 31 Mar 2015
Q4 2014 -5360% -4943% -1186% 01 Oct 2014 31 Dec 2014
Q3 2014 -2049% -1384% -208% 01 Jul 2014 30 Sep 2014
Q2 2014 -1410% -37% -2.7% 01 Apr 2014 30 Jun 2014
Q1 2014 -1150% +1786% +61% 01 Jan 2014 31 Mar 2014
Q4 2013 -417% +3002% +88% 01 Oct 2013 31 Dec 2013
Q3 2013 -665% +3704% +85% 01 Jul 2013 30 Sep 2013
Q2 2013 -1373% +713% +34% 01 Apr 2013 30 Jun 2013
Q1 2013 -2936% -1865% -174% 01 Jan 2013 31 Mar 2013
Q4 2012 -3419% 01 Oct 2012 31 Dec 2012
Q3 2012 -4369% 01 Jul 2012 30 Sep 2012
Q2 2012 -2086% 01 Apr 2012 30 Jun 2012
Q1 2012 -1070% 01 Jan 2012 31 Mar 2012

GT Biopharma, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -175% -130% -293% 01 Jan 2024 31 Dec 2024
2023 -44% +49% +53% 01 Jan 2023 31 Dec 2023
2022 -93% 01 Jan 2022 31 Dec 2022
2020 -1426% -1130% -381% 01 Jan 2020 31 Dec 2020
2019 -297% -113% -61% 01 Jan 2019 31 Dec 2019
2018 -184% -71% -63% 01 Jan 2018 31 Dec 2018
2017 -113% -6803% -102% 01 Jan 2017 31 Dec 2017
2016 6690% +11862% 01 Jan 2016 31 Dec 2016
2015 -5171% +188% +3.5% 01 Jan 2015 31 Dec 2015
2014 -5360% -4943% -1186% 01 Jan 2014 31 Dec 2014
2013 -417% +3002% +88% 01 Jan 2013 31 Dec 2013
2012 -3419% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.